Biodegradable Polymeric Based Nanoparticles for Atherosclerosis and Myocardial Infarction Targeting Potentials and Future
Journal of Cardiac Critical Care TSS · 19.01.2026 · 10 · 28-31
DOI: 10.25259/jccc_62_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Critical Care TSS, online erschienen am 19.01.2026. Verfasst von Basam Mahmoud Kasem. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Atherosclerosis and myocardial infarction are still a major concern worldwide, and the mortality incidence that is correlated to these heart abnormalities is still high, so that there is a constant need for new treatment approaches, and with the accelerated development in biomedical sciences especially at the molecular level, and with the accelerated development of material science biodegradable polymeric based nanoparticles has emerged as promising candidates for heart disorders treatment especially atherosclerosis and myocardial infarction owing to its biocompatibility, low cytotoxicity and the ability of tissues regeneration inducing capabilities.g capabilities. This review aims to highlight the efficacy of the biodegradable polymeric nanoparticles good candidates for cardiovascular system targeting that can lead to an optimal results low-adverse reactions.
Zitieren
APA
Kasem, B. M. (2026). Biodegradable Polymeric Based Nanoparticles for Atherosclerosis and Myocardial Infarction Targeting Potentials and Future. Journal of Cardiac Critical Care TSS, 10, 28-31. https://doi.org/10.25259/jccc_62_2025
Vancouver
Kasem BM. Biodegradable Polymeric Based Nanoparticles for Atherosclerosis and Myocardial Infarction Targeting Potentials and Future. Journal of Cardiac Critical Care TSS. 2026;10:28-31. doi:10.25259/jccc_62_2025
BibTeX
@article{Kasem2026,
author = {Kasem, Basam Mahmoud},
title = {Biodegradable Polymeric Based Nanoparticles for Atherosclerosis and Myocardial Infarction Targeting Potentials and Future},
journal = {Journal of Cardiac Critical Care TSS},
year = {2026},
volume = {10},
pages = {28--31},
doi = {10.25259/jccc_62_2025}
}
EUVIMED